hiatus, the extension began Oct. 1 and will remain in effect until Oct.
1, 2020. The HCPCS code is C9447. Omeros continues to pursue per-
manent separate payment for Omidria.
Cost is a major issue. One surgery center administrator says her
facility pays $395 to $450 a bottle, depending on volume. In the last
quarter, she says her facility used 300 bottles of Omidria and was
reimbursed fully for each. Eight of her of 9 cataract surgeons use it.
"If it's going to help the patient and the patient doesn't have to pay
out of pocket for it, why not use it?" she asks. "Some of my surgeons
become faster with it because they don't have to administer so many
different meds. Patients lie still longer and won't feel the pressure of
the procedure."
Anna Risdorfer, RN, director of nursing at Palisades Eye Surgery
Center in Bethesda, Md., came up with a simple way to ensure her
facility is reimbursed for Omidria. They place a green "OK to bill"
sticker next to names of the patients on the schedule whose insurers
will pay for the drug.
ReSure Sealant
ReSure Sealant seals clear corneal incisions following cataract sur-
gery. It's prepared and applied in about 20 seconds and gels in-situ,
protecting incisions in the immediate post-operative period when
wounds are most vulnerable, says Ocular Therapeutix. The hydrogel
gradually sloughs off in the tears during reepithelialization, so there is
no need for removal.
ReSure Sealant is indicated for intraoperative management of clear
corneal incisions (up to 3.5mm) with a demonstrated wound leak for
which a temporary dry surface can be achieved, in order to prevent
post-op fluid egress from such incisions following cataract surgery
with IOL placement in adults, says the company.
8 0 • O U T PA T I E N T S U R G E R Y M A G A Z I N E • N O V E M B E R 2 0 1 8
